Question

In: Biology

Binding of an agonist to an adrenergic GPCR receptor results in: A.   The GalphaS subunit dissociating...

Binding of an agonist to an adrenergic GPCR receptor results in:
A.   The GalphaS subunit dissociating from the Gbeta-Ggamma subunits.
B.   The Gbeta subunit dissociating from the GalphaS-Ggamma subunits.
C.   The Ggamma-subunit dissociating from the GalphaS-Gbeta subunits.
D.   None of the above are correct.
E.   All of the above are correct.


mTORC signaling occurs when:
A.   the cell has an energy deficit and requires more nutrients.
B.   the cell has an adequate supply of nutrients and is in a high-energy state
C.   the muscles are fatigued and require additional oxygen.

In the citric acid cycle, the acetyl-coA is linked to a pre-existing molecule of_______________.
A.   citrate (citric acid)
B.   oxaloacetate
C.   fumarate
D.   succinate
E.   pyruvate


What type of enzyme is required to catabolize an unsaturated fatty acid but not a saturated fatty acid?
dehydrogenase
mutase
hydratase  
isomerase

please answer all of it or it cannot don't answer question

Solutions

Expert Solution

1A. The G alphaS subunit dissociating from the Gbeta-G gamma subunits.

2. B.   the cell has an adequate supply of nutrients and is in a high-energy state

mTOR functions as a serine/threonine-protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, autophagy, and transcription.

3.B. Oxaloacetate

In the citric acid cycle, the acetyl group from acetyl CoA is attached to a four-carbon oxaloacetate molecule to form a six-carbon citrate molecule.

4. D. Isomerase

Enoyl-CoA isomerase is involved in the beta-oxidation, one of the most frequently used pathways in fatty acid degradation, of unsaturated fatty acids with double bonds at odd-numbered carbon positions.


Related Solutions

3- Please explain the action of adrenergic alpha 1 receptor, and adrenergic beta 2 receptor.
3- Please explain the action of adrenergic alpha 1 receptor, and adrenergic beta 2 receptor.
Upon binding of epinephrine to β-adrenergic receptor, a conformational change is propagated from its extracellular face...
Upon binding of epinephrine to β-adrenergic receptor, a conformational change is propagated from its extracellular face to its intracellular face leading to release of the G⍺ subunit and subsequent binding of GTP and activation of downstream components of the pathway.  What prevents G⍺ from indefinitely activating the fight-or-flight response? Cleavage of G⍺ subunits by Thrombin. ATIII. Intrinsic GTPase activity. GAPs GEFs Which components of GPCR signaling pathways are transmembrane proteins? GPCR G-protein Effector protein (ex: adenylyl cyclase) PKA
Diagram an adrenergic receptor. Label the ligand-binding domain. Label the transmembrane domain. Label the intracellular domain....
Diagram an adrenergic receptor. Label the ligand-binding domain. Label the transmembrane domain. Label the intracellular domain. Name a ligand for an adrenergic receptor. What happens to the adrenergic receptor when this ligand binds?
Write out the GPCR pathway showing targets of the alpha subunit.
Write out the GPCR pathway showing targets of the alpha subunit.
Critical Thinking Case Study An older adult patient has asthma, and an adrenergic agonist is selected...
Critical Thinking Case Study An older adult patient has asthma, and an adrenergic agonist is selected for treatment. What are the drug advantages and disadvantages associated with the use of an adrenergic agonist, such as metaproterenol or albuterol, for this patient? Explain your answer. Is age a factor in drug selection? Explain your answer. An older adult patient has hypertension and asthma. An adrenergic blocker is selected for treatment. What are the drug advantages and disadvantages associated with the use...
You have designed a new drug (Provasoshut®) that acts as an agonist of alpha-adrenergic receptors. In...
You have designed a new drug (Provasoshut®) that acts as an agonist of alpha-adrenergic receptors. In most of the systems you have studied (e.g. capillary beds of the digestive system, liver, and adipose), Provasoshut® causes vasoconstriction that lasts for at least 15 minutes. However, when you tried the drug on the capillary beds of the contracting muscle of the frog leg prep in your physiology lab, the vasoconstriction lasted only 20 seconds! What is the best explanation for the short-lived...
A Relaxin receptor agonist drug (RRA01) for the acute heart failure treatment is developed by the...
A Relaxin receptor agonist drug (RRA01) for the acute heart failure treatment is developed by the Sunny Pharmaceutical Company. It is a publicly traded company. The reduction of cardiovascular death (mortality) was used as the end point (results of the research) for this investigation. The null hypothesis is “there is no difference in the cardiovascular mortality reduction between patients who received RRA01 (treatment group) and those who did not receive RRA01 (control group). Discuss the impact (on the company and/or...
If an adrenergic receptor is a GCPR. Which technique below would best one to confirm that?...
If an adrenergic receptor is a GCPR. Which technique below would best one to confirm that? Hydropathy plot, FRAP analysis, or siRNA knock-down
How can you experimentally demonstrate that a specific GPCR couples through Gi alpha subunit to inhibit...
How can you experimentally demonstrate that a specific GPCR couples through Gi alpha subunit to inhibit adenylyl cyclase activity
Describe how subunit cooperativity works in the binding of O2 to hemoglobin in the lungs and...
Describe how subunit cooperativity works in the binding of O2 to hemoglobin in the lungs and the release of O2 in the tissues. Include in your response the benefit of subunit cooperativity.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT